Coming Soon: 2025 Call for Nominations  

The 2025 call for nominations to join expert and advisory committees at Canada’s Drug Agency will be open from March 3 to March 31, 2025.  

These committees play a critical role in our efforts to power evidence-informed drug and health technology decisions and improve health outcomes for people in Canada. We’ll be seeking dedicated individuals with diverse education, experience, and skill sets who can bring a wealth of knowledge, fresh perspectives, and a commitment to excellence to our table.  

We anticipate that opportunities may be available on our:  

• Canadian Drug Expert Committee (CDEC) (patient member)  
• pCODR Expert Review Committee (pERC) (expert member)
• Health Technology Expert Review Committee (HTERP) (heath technology assessment specialist member)
• Patient and Community Advisory Committee (PCAC) (members)  

Canada’s Drug Agency actively strives to build a culture of inclusion that values diverse experiences and perspectives. We welcome and encourage applications from qualified applicants from diverse backgrounds and experiences.  

Details about each role, eligibility criteria, and the nomination process will be available on our website on March 3, 2025. Subscribe to our eAlerts to be notified when the nomination period opens. Contact us with questions if you would like to learn more about the selection process before the nomination period opens.